In-vivo study: the maximal systolic acceleration in a modified arterial stenosis

In-vivo study: the maximal systolic acceleration in a modified arterial stenosis - The maximal systolic acceleration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47006

Enrollment

Registered

2018-03-20

Start date

2017-08-31

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

claudicatio intermittens Peripheral arterial disease

Interventions

Ankle Brachial Index

Duplex

In-vivo study

Maximal systolic acceleration

Peripheral arterial disease

Toe pressure

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy test subjects between 18 and 30 years old.

Exclusion criteria

Exclusion criteria: Test subjects with peripheral arterial disease, diabetes mellitus, renal insufficiency, Raynaud's phenomenon.

Design outcomes

Primary

Measure	Time frame
Ankle-brachial index (ABI), toe pressure and maximal systolic acceleration (ACC max).	—

Secondary

Measure	Time frame
Niet van toepassing.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)